Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: Effects of 7-nitroindazole and zaprinast

European Journal of Pharmacology

Volumn 337, Issue 2-3, 1997, Pages 125-136

  Prickaerts, Jos ^a   Steinbusch, Harry W M ^a   Smits, Jos F M ^a   De Vente, Jan ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

7 Nitroindazole; Blood pressure; cGMP; Memory; Nitric oxide (NO); Rat; Zaprinast

Indexed keywords

7 NITROINDAZOLE; CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; ZAPRINAST;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; LONG TERM POTENTIATION; MALE; MEAN ARTERIAL PRESSURE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD PRESSURE; CYCLIC GMP; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; INDAZOLES; MALE; MEMORY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE INHIBITORS; PURINONES; RATS; SIGNAL TRANSDUCTION; VISUAL PERCEPTION;

EID: 0030688947     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01301-0     Document Type: Article

References (60)

1. Arancio O., Kandel E.R., Hawkins R.D. Activity-dependent long-term enhancement of transmitter release by presynaptic 3′,5′-cyclic GMP in cultured hippocampal neurons. Nature. 376:1995;74-80.
2. Babbedge R.C., Bland Ward P.A., Hart S.L., Moore P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol. 110:1993;225-228.
3. Bannerman D.M., Butcher S.P., Morris R.G. Intracerebroventricular injection of nitric oxide synthase inhibitor does not affect long-term slope potentiation in vivo. Neuropharmacology. 33:1995;1387-1397.
4. Bannerman D.M., Chapman P.F., Kelly P.A.T., Butcher S.P., Morris R.G.M. Inhibition of nitric oxide synthase does not impair spatial learning. J. Neurosci. 14:1994;7404-7414.
5. Bannerman D.M., Chapman P.F., Kelly P.A.T., Butcher S.P., Morris R.G.M. Inhibition of nitric oxide synthase does not prevent the induction of long-term potentiation in vivo. J. Neurosci. 14:1994;7415-7425.
6. Beavo J.A., Reifsnyder D.H. Primary sequence of cyclic nucleotide phophodiesterase isoenzymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11:1990;150-155.
7. Bernabeu R., de Stein M.L., Fin C., Izquierdo I., Medina J.H. Role of hippocampal NO in the acquisition and consolidation of inhibitory avoidance learning. NeuroReport. 6:1995;1498-1500.
8. Bernabeu R., Schmitz P., Faillace M.P., Izquierdo I., Medina J.H. Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning. NeuroReport. 7:1996;585-588.
9. Bernabeu R., Schroder N., Quevedo J., Cammarota M., Izquierdo I., Medina J.H. Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation. NeuroReport. 8:1997;2221-2224.
10. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
11. Böhme G.A., Bon C., Lemaire M., Reibaud M., Piot O., Stutzmann J.-M., Doble A., Blanchard J.-C. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc. Natl. Acad. Sci. USA. 90:1993;9191-9194.
12. Bon C., Böhme G.A., Doble A., Stutzmann J.-M., Blanchard J.-C. A role for nitric oxide in long-term potentiation. Eur. J. Pharmacol. 4:1992;420-424.
13. Boulton C.L., Irving A.J., Southam E., Potier B., Garthwaite J., Collingridge G.L. The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur. J. Neurosci. 6:1994;1528-1535.
14. Boulton C.L., Southam E., Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience. 69:1995;699-703.
15. Chapman P.F., Atkins C., Allen M.T., Haley J.E., Steinmetz J.E. Inhibition of nitric oxide synthesis impairs two different forms of learning. NeuroReport. 3:1992;567-570.
16. Connop B.P., Rolfe N.G., Boegman R.J., Jhamandas K., Beninger R.J. Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole. Neuropharmacology. 33:1994;1439-1445.
17. Dawson T.M., Dason V.L., Snyder S.H. A novel neuronal messenger molecule in brain: The free radical, nitric oxide. Ann. Neurol. 32:1992;297-311.
18. De Vente J., Bol J.G.J.M., Berkelmans H.S., Schipper J., Steinbusch H.W.M. Immunocytochemistry of cGMP in the cerebellum of the immature, adult and aged rat: The involvement of nitric oxide. A micropharmacological study. Eur. J. Neurosci. 2:1990;845-862.
19. De Vente J., Hopkins D.A., Markerink van Ittersum M., Steinbusch H.W. Effects of the 3′,5′-phosphodiesterase inhibitors isobutylmethylxanthine and zaprinast on NO-mediated cGMP accumulation in the hippocampus slice preparation: An immunocytochemical study. J. Chem. Neuroanat. 10:1996;241-248.
20. Dinerman J.L., Dawson T.M., Schell M.J., Snowman A., Snyder S.H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity. Proc. Natl. Acad. Sci. USA. 91:1994;4214-4218.
21. Doyle C., Hölscher C., Rowman M.J., Anwyl R. The selective neuronal nitric oxide synthase antagonist 7-nitro indazole blocks both long-term potentiation and depotentiation of field excitatory postsynaptic potentials in rat hippocampal CA1 in vivo. J. Neurosci. 16:1996;418-424.
22. Dundore R.L., Clas D.M., Wheeler L.T., Habeeb P.G., Bode D.C., Buchholz R.A., Silver P.J., Pagani E.D. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats. Eur. J. Pharmacol. 249:1993;293-297.
23. Dundore R.L., Habeeb P.G., Pratt P.F., Becker L.T., Clas D.M., Buchholz R.A. Differential hemodynamic responses to selective inhibitors of cyclic nucleotide phosphodiesterases in conscious rats. J. Cardiovasc. Pharmacol. 19:1992;937-944.
24. Dundore R.L., Pratt P.F., Hallenbeck W.D., Wassey M.L., Silver P.J., Buchholz R.A. Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in rats. Eur. J. Pharmacol. 185:1990;91-97.
25. Dundore R.L., Pratt P.F., O'Connor B., Buchholz R.A., Pagani E.D. N-omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast. Eur. J. Pharmacol. 200:1991;83-87.
26. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data. Behav. Brain Res. 31:1988;47-59.
27. Estall L.B., Grant S.J., Cicala G.A. Inhibition of nitric oxide (NO) production selectively impairs learning and memory in the rat. Pharmacol. Biochem. Behav. 46:1993;959-962.
28. Fin C., Cunha C.A., Bromberg E., Schmitz P.K., Bianchin M., Medina J.H., Izquierdo I. Experiments suggesting a role for nitric oxide in the hippocampus in memory processes. Neurobiol. Learn. Mem. 63:1995;113-115.
29. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14:1991;60-67.
30. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57:1995;683-706.
31. Hölscher C., McGlinchey L., Anwyl R., Rowan M.J. 7-Nitro indazole, a selective neuronal nitric oxide synthase inhibitor in vivo, impairs spatial learning in the rat. Learn. Mem. 2:1996;267-278.
32. Huang A.M., Lee E.H. Role of hippocampal nitric oxide in memory retention in rats. Pharmacol. Biochem. Behav. 50:1995;327-332.
33. Iadecola C., Pelligrino D.A., Moskovitz M.A., Lassen N.A. Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 14:1994;175-192.
34. Kantor D.B., Lanzrein M., Stary J., Sandoval G.M., Smith B., Sullivan B.M., Davidson N., Schuman E.M. A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue. Science. 274:1996;1744-1748.
35. Kelly P.A.T., Ritchie I.M., Arbuthnott G.W. 7-nitro indazol uncouples cerebral blood flow from metabolic demand in the conscious rat. Br. J. Pharmacol. 112:1994;348P.
36. Kelly P.A.T., Ritchie I.M., Arbuthnutt G. Inhibition of neuronal nitric oxide synthase by 7-nitroindazol: Effects upon local cerebral blood flow and glucose use in the rat. J. Cereb. Blood Flow Metab. 15:1995;766-773.
37. MacKenzie G.M., Rose S., Bland Ward P.A., Moore P.K., Jenner P., Marsden C.D. Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. NeuroReport. 5:1994;1993-1996.
38. Meyer, R.C., Spangler, E.L., Patel, N., Ingram, D.K., 1996. Inhibition of neuronal nitric oxide synthase impairs learning of rats in a 14-unit T-maze. Soc. Neurosci. 22, 139, 62.3.
39. Mogensen J., Wörtwein G., Gustafson B., Ermens P. L-Nitroarginine reduces hippocampal mediation of place learning in the rat. Neurobiol. Learn. Mem. 64:1995;17-24.
40. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., Hart S.L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993;296-297.
41. Murad F., Mittal C.K., Arnold W.P., Katsuki S., Kimura H. Guanylate cyclase: Activation by azide, nitro compounds, nitric oxide and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv. Cyclic Nucleotide Res. 9:1978;145-158.
42. O'Dell T.J., Hawkins R.D., Kandel E.R., Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: Evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. USA. 88:1991;11285-11289.
43. O'Dell T.J., Huang P.L., Dawson T.M., Dinerman J.L., Snyder S.H., Kandel E.R., Fishman M.C. Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science. 265:1994;542-546.
44. Ohno M., Yamamoto T., Watanabe S. Deficits in working memory following inhibition of hippocampal nitric oxide synthesis in the rat. Brian Res. 632:1993;36-40.
45. Palmer R.M.J., Ferrige A.G., Mancada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
46. Prickaerts, J., de Vente, J., Raaijmakers, W., Steinbusch, H.W.M., 1996. Involvement of the nitric oxide/cyclic GMP system in object recognition memory of the rat. Soc. Neurosci. 22, 139, 62.2.
47. Sandi C., Venero C., Guaza C. Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats. Eur. J. Pharmacol. 277:1995;89-97.
48. Schmidt H.H.H.W., Lohmann S.M., Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta. 1178:1993;153-175.
49. Schuman E.M., Madison D.V. Nitric oxide and synaptic function. Annu. Rev. Neurosci. 17:1994;153-183.
50. Son H., Hawkins R.D., Martin K., Kiebler M., Huang P.L., Fishman M.C., Kandell E.R. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell. 87:1996;1015-1023.
51. Southam E., Garthwaite J. The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology. 32:1993;1267-1277.
52. Svenningsson P., Johansson B., Fredholm B.B. Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum. Acta. Physiol. Scand. 154:1995;17-24.
53. Tobin J.R., Gorman L.K., Baxter M.G., Traystman R.J. Nitric oxide synthase inhibition does not impair visual or sptial discrimination learning. Brain Res. 694:1995;177-182.
54. Toyoda M., Saito H., Matsuki N. Nitric oxide but not carbon monoxide is involved in spatial learning of mice. Jpn. J. Pharmacol. 71:1996;205-211.
55. Wilson R.I., Yanovsky J., Godecke A., Stevens D.R., Schrader J., Haas H.L. Endothelial nitric oxide synthase and LTP. Nature. 386:1997;338.
56. Yamada K., Hiramatsu M., Noda Y., Mamiya T., Murai M., Kameyama T., Komori Y., Nikai T., Sugihara H., Nabeshima T. Role of nitric oxide and cGMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience. 74:1996;365-374.
57. Yamada K., Noda Y., Nakayama S., Komori Y., Sugihara H., Hasegawa T., Nabeshima T. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br. J. Pharmacol. 115:1995;852-858.
58. Zagvazdin Y., Sancesario G., Wang Y.-X., Share L., Fitzgerald M.E.C., Reiner A. Evidence from its cardiovascular effects that 7-nitroindazol may inhibit endothelial nitric oxide synthase in vivo. Eur. J. Pharmacol. 303:1996;61-69.
59. Zhuo M., Hu Y., Schultz C., Kandel E.R., Hawkins R.D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature. 368:1994;635-639.
60. Zufall F. Cyclic nucleotide-gated channels, nitric oxide and neural function. Neuroscientist. 2:1995;24-32.